VRIDOZIL M 5/5 TABLET 5 mg + 5 mg (SGK Choice)
Active Salt Composition:
Donepezil 5mg + Memantine 5mg
Product Specifications & Information
| Product Name | VRIDOZIL M 5/5 TABLET 5 mg + 5 mg |
| Brand | VRIDOZIL M 5/5 TABLET |
| Active Salt / Composition | Donepezil 5mg + Memantine 5mg |
| Dosage Form | Tablet |
| Strength | 5 mg + 5 mg |
| Pack Size | Strip of 10 Tablets |
| Release Type | Immediate Release |
| Route of Administration | Oral |
| Manufacturer | Vridam |
| Maximum Retail Price (MRP) | ₹103.13 |
| Selling Price | ₹55 (Save 47%) |
| Availability | In Stock (Ready to dispatch) |
| SKU / Item Code | vridozil-m-5-5-tablet-donepezil-memantine |
| Regulatory Schedule | Schedule H (Prescription Required) |
| Prescription Status | Prescription Required (Schedule H/H1 Verified) |
About & Therapeutic Indications
VRIDOZIL M 5/5 TABLET is a specialized therapeutic agent designed to address the complex symptoms of Alzheimer's disease. Within the Brain & Mental Health category, this medication serves as a dual-action treatment. Donepezil works by increasing the levels of acetylcholine, a neurotransmitter essential for memory and learning, while Memantine regulates the activity of glutamate, preventing excitotoxicity that can damage brain cells. By utilizing VRIDOZIL M 5/5 TABLET, patients may experience a stabilization of cognitive decline, improved behavioral symptoms, and a better quality of life. It is essential that VRIDOZIL M 5/5 TABLET is administered under the strict supervision of a neurologist or geriatrician, as it requires careful titration to ensure efficacy and minimize potential cholinergic side effects. This medication is not a cure but a vital tool in managing the progression of dementia-related conditions.